List of Veeva QualityDocs Customers
Pleasanton, 94588, CA,
United States
Since 2010, our global team of researchers has been studying Veeva QualityDocs customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva QualityDocs for Document Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva QualityDocs for Document Management include: Samsung Biologics Co, a South Korea based Life Sciences organisation with 4400 employees and revenues of $1.20 billion, Atara Biotherapeutics, a United States based Professional Services organisation with 334 employees and revenues of $64.0 million, Aspen Pharma Ireland, a Ireland based Life Sciences organisation with 55 employees and revenues of $23.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva QualityDocs, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva QualityDocs customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Aspen Pharma Ireland | Life Sciences | 55 | $23M | Ireland | Veeva Systems | Veeva QualityDocs | Document Management | 2014 | n/a | In 2014, Aspen Pharma Ireland deployed Veeva QualityDocs as its Regulatory Affairs electronic document management solution. The implementation targeted Document Management for regulated quality and regulatory documentation managed from the Ireland site under the company IT strategy. Veeva QualityDocs was configured to enforce controlled document lifecycle management, version control, approval workflows, audit trails, electronic signatures and role based access for SOPs and regulatory submission artifacts. Configuration work emphasized validation ready settings and auditability consistent with pharmaceutical compliance requirements. The Veeva QualityDocs rollout was provisioned in an environment that included Microsoft SharePoint for artwork management, Trackwise for change control, Veeva RIMS for regulatory data, eCTD Manager for submission packaging and Argus Safety for pharmacovigilance, with the system deployed alongside these enterprise applications. Operational ownership rested with the Aspen Pharma Ireland IT organization and the global IT team, aligning the deployment to existing infrastructure and monitoring standards. Procurement, due diligence and vendor compliance lifecycle processes were completed as part of the deployment, and global computer systems validation and IT regulatory requirements were applied to the Veeva QualityDocs implementation. Governance actions included formal validation protocols, vendor lifecycle audit readiness and implementation of operational procedures to protect information assets. | |
 |
Atara Biotherapeutics | Professional Services | 334 | $64M | United States | Veeva Systems | Veeva QualityDocs | Document Management | 2020 | n/a | In 2020, Atara Biotherapeutics implemented Veeva QualityDocs to centralize controlled documentation and support regulated content lifecycles. The Veeva QualityDocs deployment served as the company Document Management platform and was executed alongside a broader Veeva Systems program covering quality, regulatory, clinical, and commercial applications. The implementation encompassed Veeva QualityDocs core document control capabilities and was coordinated with Veeva QMS and the Veeva RIM Suite, with the Submissions Content Planning and Publishing modules of Veeva RIM successfully delivered. Operational responsibilities also included Veeva eTMF for clinical content, PromoMats and MedComms for promotional and medical communications, and Veeva CRM for commercial engagement, while the learning management function was managed with UL ComplianceWire. Governance and rollout were driven by manufacturing quality and regulatory system validation ownership, with process controls and validation activities aligned to support Regulatory Operations and Manufacturing QA. The capital project schedule was compressed by more than 50 percent to meet a corporate milestone to reduce spending and to equip Regulatory Operations to perform submissions work in-house. | |
 |
Samsung Biologics Co | Life Sciences | 4400 | $1.2B | South Korea | Veeva Systems | Veeva QualityDocs | Document Management | 2020 | n/a | In 2020, Samsung Biologics Co implemented Veeva QualityDocs to centralize Document Management for enterprise quality and document control across its global manufacturing footprint. The deployment was delivered on Veeva Systems cloud infrastructure and positioned Veeva QualityDocs alongside Veeva Vault QMS as components of the Veeva Vault Quality Suite to unify quality process and content management across the product lifecycle. The implementation focused on core Document Management capabilities, including controlled document authoring, version control, formal approval workflows, role-based access controls, and content lifecycle management to support regulated quality processes. Configuration work emphasized harmonizing document taxonomy and approval workflows to align manufacturing, development, and laboratory testing documentation with enterprise quality rules and regulatory requirements. Operationally the rollout incorporated internal organization stakeholders and external parties, bringing Samsung Biologics Co, its pharmaceutical and biotech customers, contract manufacturers, and suppliers into a single quality content environment. The scope covered development, manufacturing, and laboratory testing functions, aiming to provide transparency for internal and external reviewers and to standardize document exchange and review across sites. Governance changes targeted process harmonization and end-to-end quality visibility, enabling centralized oversight of document control and closer alignment between quality content and quality processes. Reported outcomes in the public announcement included improved visibility and compliance across global manufacturing and more efficient document control and management as part of Samsung Biologics Co’s broader quality management strategy. |
Buyer Intent: Companies Evaluating Veeva QualityDocs
- eInfochips, a United States based Professional Services organization with 3000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||